The Effect of Preanalytical Conditions on Blood-Based Inflammation Biomarkers
Blood-based inflammation biomarkers have potential for diagnostic, prognostic, and predictive testing, but preanalytical processing conditions can affect biomarker levels. We investigated how needle-to-freezer time, centrifugation timing, and tube types influence inflammation biomarkers. Twenty subjects donated 21 different blood samples in collection tubes, including plasma and serum types. Ninety-two biomarkers from each sample were analyzed using the Olink Target 96 Inflammation panel. We compared biomarker concentrations across different preanalytical variables to a reference standard tube. Intraclass, Pearson, and Spearman's correlation coefficients were calculated. We also assessed the impact of these conditions on age-related associations with biomarkers. Across the preprocessing protocol/blood matrix combinations, 38%-83%, 50%-87%, and 47%-79% of proteins showed good to excellent correlations in intraclass, Pearson, and Spearman analyses, respectively. Eighteen proteins differed by >0.5 NPX units between test and reference protocols. Among 30 comparisons of age-related biomarker associations showing <i>p</i> ≤ 0.05 at baseline, 12 (40%) maintained a <i>p</i> ≤ 0.05 across all needle-to-freezer times. Many proteins in the Olink Target 96 Inflammation panel exhibited robust stability across various preanalytical conditions, indicating that blood-based inflammation biomarkers are suitable for testing across different blood specimen types. Further studies are needed to evaluate the impact of long-term storage.
Authors
- Norma Diaz-Mayoral (ORCID: https://orcid.org/0009-0009-6221-5772)
- Yukiko Yano (ORCID: https://orcid.org/0000-0001-9816-0384)
- Christian C. Abnet (ORCID: https://orcid.org/0000-0002-3008-7843)
- Paul S. Albert (ORCID: https://orcid.org/0000-0003-1658-1068)
- Stephanie J. Weinstein (ORCID: https://orcid.org/0000-0002-3834-1535)
- Katrina Wyatt (ORCID: https://orcid.org/0000-0001-7099-159X)
- Alaina H. Shreves (ORCID: https://orcid.org/0000-0002-0127-4391)
- Nicolas Wentzensen (ORCID: https://orcid.org/0000-0003-1251-0836)
- Michelle Brotzman
- Amanda Black (ORCID: https://orcid.org/0000-0002-2245-3428)
- Thomas J. O'Donnell
- Nicole Gerlanc
- Mia M. Gaudet
Institutions
- National Institutes of Health (US)
- University of Oxford (GB)
- Nuffield Health (GB)
- Bioprocess Control (Sweden) (SE)
- Frederick National Laboratory for Cancer Research (US)
- Cancer Genetics (United States) (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- Journal of Proteome Research
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1021/acs.jproteome.5c00225
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Cancer Institute